No excess risk of cervical carcinoma among women seropositive for both HPV16 and HPV6/11

International Journal of Cancer

Volumn 80, Issue 6, 1999, Pages 818-822

  Luostarinen, Tapio ^a   Af Geijersstam, Veronika ^b   Bjørge, Tone ^c,d   Eklund, Carina ^b   Hakama, Matti ^e,f   Hakulinen, Timo ^g,h   Jellum, Egil ^d   Koskela, Pentti ⁱ   Paavonen, Jorma ^h   Pukkala, Eero ^a   Schiller, John T ^j   Thoresen, Steinar ^c   Youngman, Linda D ^k   Dillner, Joakim ^e,l   Lehtinen, Matti ⁱ  

^a FINNISH CANCER REGISTRY   (Finland)

^b KAROLINSKA INSTITUTE   (Sweden)

^c CANCER REGISTRY OF NORWAY   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF TAMPERE   (Finland)

^f GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^g KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^h UNIVERSITY OF HELSINKI   (Finland)

ⁱ NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^j NATIONAL CANCER INSTITUTE   (United States)

^k UNIVERSITY OF OXFORD   (United Kingdom)

^l UMEÅ UNIVERSITY   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

COTININE;

ARTICLE; CANCER PREVENTION; CANCER REGISTRY; CANCER RISK; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; SERODIAGNOSIS; SEROPREVALENCE; SEXUAL BEHAVIOR; SMOKING; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA; VIRUS CARCINOGENESIS; VIRUS IMMUNITY; WART VIRUS;

EID: 0033559584     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990315)80:6<818::AID-IJC4>3.0.CO;2-T     Document Type: Article

References (23)

1. BARDY, A.H., SEPPÄLÄ, T., LILLSUNDE., P., KATAJA, J.M., KOSKELA, P., PIKKARAINEN, J. and HIILESMAA, V.K., Objectively measured tobacco exposure during pregnancy: neonatal effects and relation to maternal smoking. Brit. J. Obstet. Oncol., 100, 721-726 (1993).
2. BJØRGE, T. and KRAVDAL, Ø., Reproductive variables and risk of uterine cervical cancer in Norwegian registry data. Cancer Causes Control. 7, 351-357 (1996).
3. BRINTON, L.A., REEVES, W.C., BRENES, M.M., HERRERO, R., DE BRITTON, R.C., GAITAN, E., TENORIO, F., GARCIA, M. and RAWLS, W.E., Parity as a risk factor for cervical cancer. Amer. J. Epidemiol., 130, 486-496 (1989).
4. CARTER, J.J., KOUTSKY, L.A., WIPF, G.C., CHRISTENSEN, N.D., LEE, S.K., KUYPERS, J., KIVIAT, N. and GALLOWAY, D.A., The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women. J. infect. Dis., 174, 927-936 (1996).
5. DE GRUIJL, T.D., BONTKES, H.J., WALBOOMERS, J.M., SCHILLER, J.T., STUKART, M.J., GROOT, B.S., CHABAUD, M.M.R., REMMINK, A.J., VERHEIJEN, R.H.M., HELMERHORST, T.J.M., MEIJER, C.J.L.M. and SCHEPER, R.J., Immunoglobulin G responses against human papillomavirus type 16 virus-like particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia. J. nat. Cancer Inst., 89, 630-638 (1997).
6. DILLNER, J., KALLINGS, I., BRIHMER, C., SIKSTRÖM, B., KOSKELA, P., LEHTINEN, M., SCHILLER, J.T., SAPP, M. and MARDH, P.A., Seropositivities to human papillomavirus types 16, 18, or 33 capsids and to Chlamydia trachomatis are markers of sexual behavior. J. infect. Dis., 173, 1394-1398 (1996).
7. DILLNER, J. and 14 OTHERS, Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer. J. nat. Cancer Inst., 89, 1293-1299 (1997).
8. DILLNER, J., LENNER, P., LEHTINEN, M., EKLUND, C., HEINO, P., WIKLUND, F., HALLMANS, G. and STENDAHL, U., A population-based seroepidemiological study of cervical cancer. Cancer Res., 54, 134-141 (1994).
9. DONATO, F., BOFFETTA, P. and PUOTI, M., A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C-virus infections in causing hepatocellular carcinoma. Int. J. Cancer, 75, 347-354 (1998).
10. ENGELAND, A., HALDORSEN, T., TRETLI, S., HAKULINEN, T., HÖRTE, L.G., LUOSTARINEN, T., MAGNUS, K., SCHOU, G., SIGVALDASON, H., STORM, H.H., TULINIUS, H. and VAITTINEN, P., Prediction of cancer incidence in the Nordic countries up to the years 2000 and 2010. A collaborative study of the five Nordic cancer registries. Acta pathol. microbiol. immunol. scand., 101, Suppl. 38 (1993).
11. FRANCO, E.L., The sexually transmitted disease model for cervical cancer: incoherent epidemiologic findings and the role of misclassification of human papillomavirus infection. Epidemiology, 2, 98-106 (1991).
12. IARC, Human papillomaviruses. IARC Monographs on the evaluation of carcinogenic risks of chemicals to humans, Vol. 64, IARC, Lyon (1995).
13. JELLUM, E., ANDERSEN, A., LUND-LARSEN, P., THEODORSEN, L. and ØRJASÆTER, H., Experiences of the Janus serum bank in Norway. Environ. Health Perspect., 103, Suppl. 3, 85-88 (1995).
14. KJÆR, S.K., Risk factors for cervical neoplasia in Denmark. Acta pathol. microbiol. immunol. scand., 106, Suppl. 80, 1-41 (1998).
15. LEHTINEN, M., DILLNER, J., KNEKT, P., LUOSTARINEN, T., AROMAA, A., KIRNBAUER, R., KOSKELA, P., PAAVONEN, J., PETO, R., SCHILLER, J.T. and HAKAMA, M., Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: nested case-control study. Brit. med. J., 312, 537-539 (1996).
16. LIPSITCH, M., Vaccination against colonizing bacteria with multiple serotypes. Proc. nat. Acad. Sci. (Wash.), 94, 6571-6576 (1997).
17. PARISH, S., COLLINS, R., PETO, R., YOUNGMAN, L., BARTON, J., JAYNE, K., CLARKE, R., APPLEBY, P., LYON, V., CEDERHOLM-WILLIAMS, S., MARSHALL, J. and SLEIGHT, P., Cigarette smoking, tar yields, and non-fatal myocardial infarction: 14,000 cases and 32,000 controls in the United Kingdom. The International Studies of Infarct Survival (ISIS) Collaborators. Brit. med. J., 311, 471-477 (1995).
18. PUKKALA, E., Use of record linkage in small-area studies. In: P. Elliott, J. Cuzick, D. English and R. Stern (eds.), Geographical and environmental epidemiology: methods for small-area studies, pp. 125-131, Oxford University Press, Oxford (1992).
19. RODEN, R.B., GREENSTONE, H.L., KIRNBAUER, R., BOOY, F.P., JESSIE, J., LOWY, D.R. and SCHILLER, J.T., In vitro generation and type-specific neutralization of a human papilloma-virus, type 16 virion pseudotype. J. Virol., 70, 5875-5883 (1996).
20. SHAH, K.V. and HOWLEY, P.M., Papillomaviruses. In: B.N. Fields, D.M. Knipe, P.M. Howley, R.M. Chanock, J.L. Melnick, T.P. Monath, B. Roizman and S.E. Straus (eds.), Fields virology, 3rd ed., pp. 2077-2109, Lippincott-Raven, Philadelphia (1996).
21. SHAH, K.V., VISCIDI, R.P., AHLBERG, A.J., HELZLSOUER, K.J. and COMSTOCK, G.W., Antibodies to human papillomavirus 16 and subsequent in situ or invasive cancer of the cervix. Cancer Epidemiol. Biomarkers Prev., 6, 233-237 (1997).
22. WANG, S.-P. and GRAYSTON, J.T., Immunologic relationship between genital TRIC, lymphogranuloma venereum, and related organisms in a new microtiter indirect immunofluorescence test. Amer. J. Ophthalmol., 70, 367-374 (1970).
23. WIDEROFF, L. and 15 OTHERS, Epidemiologic determinants of seroreactivity to human-papillomavirus(HPV) type 16 virus-like particles in cervical HPV-16-DNA-positive and -negative women. J infect. Dis., 174, 937-943 (1996).